Between risk charts and imaging: how should we stratify cardiovascular risk in clinical practice?

Mureddu, Gian Francesco; Brandimarte, Filippo; Faggiano, Pompilio; Rigo, Fausto; Nixdorff, Uwe
May 2013
European Heart Journal - Cardiovascular Imaging;May2013, Vol. 14 Issue 5, p401
Academic Journal
Cardiovascular (CV) risk prediction has a central role in primary CV prevention. Several risk charts have been developed in the attempt to identify subjects at risk who might benefit from more aggressive interventions. However, risk charts show main limitations and they remain underutilized in general practice. The addition of novel risk markers has substantially failed to improve risk charts discrimination power. Imaging has recently gained relevance in CV risk stratification for its ability to detect subclinical atherosclerosis. Although extending non-invasive imaging to all asymptomatic middle-aged people is currently not recommended, its progressive spread may provide information on preclinical atherosclerosis and detection of de facto initial disease might overcome some limitations of conventional risk stratification charts.


Related Articles

  • Imaging cardiac fat. Davidovich, Daniel; Gastaldelli, Amalia; Sicari, Rosa // European Heart Journal - Cardiovascular Imaging;Jul2013, Vol. 14 Issue 7, p625 

    Ectopic fat deposition has been associated with lipotoxicity and derangement in local and systemic metabolism, insulin resistance, cardiac dysfunction, atherosclerosis, local, and systemic inflammation. The mechanisms and potentially detrimental effects of such an accumulation should be fully...

  • Approaches to More Refined Cardiovascular Risk Assessment. Kernan, Michael; Malvasi, Anthony J. // Family Doctor: A Journal of the New York State Academy of Family;Spring2014, p8 

    The article discusses the assessment of risk factors in patients with coronary heart disease such as leukocyte count, lipoprotein level and arterial brachial index (ABI) and cites the use of Framingham risk model in determining the patient's risk level.

  • Cardiovascular risk assessment in children with chronic kidney disease. Shroff, Rukshana; Dégi, Arianna; Kerti, Andrea; Kis, Éva; Cseprekál, Orsolya; Tory, Kálmán; Szabó, Attila; Reusz, George // Pediatric Nephrology;Jun2013, Vol. 28 Issue 6, p875 

    Chronic kidney disease (CKD) is a major factor contributing to cardiovascular (CV) morbidity and mortality with the highest risk in patients on dialysis. An estimation of CV risk is important not only to identify potential modifiable risk factors but also to evaluate the effect of treatments...

  • High-Sensitivity C-Reactive Protein and Statin Initiation. Trpkovic, Andreja; Stanimirovic, Julijana; Rizzo, Manfredi; Resanovic, Ivana; Soskic, Sanja; Jevremovic, Danimir; Isenovic, Esma R. // Angiology;Jun2015, Vol. 66 Issue 6, p503 

    The assessment of cardiovascular risk and treatment of cardiovascular diseases are major public health issues worldwide. Inflammation is now recognized as a key regulatory process that links multiple risk factors for atherosclerosis. The substantial number of patients having cardiovascular...

  • Making the case for a more accurate cardiovascular disease risk assessment tool for Indigenous Australians. Chan, Alex // Contemporary Nurse: A Journal for the Australian Nursing Profess;2015, Vol. 50 Issue 1, p92 

    The article focuses on a study conducted by authors on risk assessment tool of cardiovascular disease (CVD). Topics discussed include high statistic of morbidity and mortality from CVD, preventive treatment based on individual's risk assessment score, factors contributing to CVD are historical...

  • The Role of Carotid Ultrasound for Cardiovascular Risk Stratification beyond Traditional Risk Factors. Chan Joo Lee; Sungha Park // Yonsei Medical Journal;May2014, Vol. 55 Issue 3, p551 

    Primary prevention and early detection of cardiovascular disease is important, as it is the leading cause of death throughout world. Risk stratification algorithms, such as Framingham Risk Score and European Systematic Coronary Risk Evaluation, that utilize a combination of various traditional...

  • The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran. Sepanlou, Sadaf G.; Malekzadeh, Reza; Poustchi, Hossein; Sharafkhah, Maryam; Ghodsi, Saeed; Malekzadeh, Fatemeh; Etemadi, Arash; Pourshams, Akram; Pharoah, Paul D.; Abnet, Christian C.; Brennan, Paul; Boffetta, Paolo; Dawsey, Sanford M.; Kamangar, Farin // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood...

  • Cardiovascular risk assessment and lipid modification: NICE guideline. Duerden, Martin; O'Flynn, Norma; Qureshi, Nadeem // British Journal of General Practice;Jul2015, Vol. 65 Issue 636, p378 

    The article discusses the recommendations and implications of the updated guidance on cardiovascular risk assessment and blood lipids modification released by the National Institute for Health and Care Excellence (NICE). Topics discussed include the use of QRISK®2 as cardiovascular risk...

  • JBS3: Prevention of CVD.  // Pulse;Apr2014, p18 

    The article offers information on the Joint British Societies (JBS)3 risk calculator which was created to determine the lifetime and 10-year risk of cardiovascular disease (CVD) in all individuals and the prevention of CV.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics